Sirtris Pharmaceuticals, Inc. · Cambridge, MA United States
| 200 Technology Sq. | Phone: 617-252-6920 |
| Cambridge, MA | Fax: 617-252-6924 |
| 02139 | |
| United States | 
Map This Company |
Sirtris Pharmaceuticals, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Sirtris can help keep you healthy in your golden years. The biopharmaceutical company focuses on developing drugs for treating ailments of aging. Its primary candidate is designed to treat Type 2 Diabetes, which is associated with obesity, by providing health benefits similar to calorie restriction without a change in diet. Other candidates include drugs to treat cancer, cardiovascular, and other diseases often linked to obesity. Sirtris owns or licenses several patent applications for sirtuins, a class of enzymes believed to be associated with the aging process. The activation of sirtuins helps reduce weight gain and improve glucose levels and insulin sensitivity. Sirtris is a subsidiary of
Sirtris Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | SubsidiarySingle Location |
|---|---|
| Fiscal Year-End | December |
| Employees | 57 |
Executives
24 executives listed for Sirtris Pharmaceuticals, Inc.'s Cambridge, MA location.
| CEO | Christoph Westphal | |
|---|---|---|
| COO | Garen Bohlin | |
| VP Finance | Paul Brannelly |